Methylation-Specific PCR

João Ramalho-Carvalho1,2, Rui Henrique1,3,4, Carmen Jerónimo5,6,7

  • 1Cancer Biology and Epigenetics Group; Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.

Insights

DNA methylation, a key epigenetic modification, influences gene expression and is linked to diseases. Methylation-Specific PCR (MSP) offers a sensitive method for analyzing DNA methylation patterns and discovering novel biomarkers for clinical use.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Genomics

Background:

  • Cytosine methylation is a crucial epigenetic modification impacting gene transcription.
  • Dysregulation of DNA methylation is implicated in various human diseases, including cancers.
  • Understanding DNA methylation dynamics is vital for disease mechanism elucidation and biomarker discovery.

Purpose of the Study:

  • To investigate the role of DNA methylation in disease pathogenesis.
  • To highlight the potential of DNA methylation analysis for biomarker development.
  • To introduce Methylation-Specific PCR (MSP) as a powerful tool for studying DNA methylation.

Main Methods:

  • Methylation-Specific PCR (MSP) is employed to analyze the methylation status of specific gene loci.
  • MSP allows for the rapid detection of methylation within CpG islands.
  • The technique requires minimal DNA input and is highly sensitive.

Main Results:

  • MSP can accurately determine the methylation status of CpG sites.
  • The method is sensitive enough to detect low levels of methylated alleles (<0.1%).
  • MSP is versatile and applicable to various sample types, including bodily fluids and archival tissues.

Conclusions:

  • DNA methylation serves as a potential epigenetic memory module, with patterns changing during development and disease.
  • MSP is a robust and widely applicable technique for DNA methylation analysis.
  • DNA methylation analysis holds significant promise for identifying novel biomarkers for clinical applications.